VIBATIV® Mechanism of Action

GlaxoSmithKline (gsk) commissioned XVIVO to create a mechanism of action animation for VIBATIV® (televancin), used in the treatment of hospital-acquired MRSA. VIBATIV® works by inhibiting cell wall synthesis, severely restricting cellular replication.



XVIVO really came through for us when we were putting together animations for the Health gallery of the Connecticut Science Center. The beating heart is gorgeous! They are true experts and we really enjoyed collaborating with them.

Shannon Densmore, Executive Producer, Boston Productions, INC.